Department of Microbiology and Immunology,
School of Medicine, Medical College of Virginia at Virginia
Commonwealth University, Richmond, Virginia
23298-0678,1 and Department of
Microbiology and Immunology, The Texas A & M University System
Health Science Center, College Station, Texas
77843-11142
Numerous studies have provided suggestive evidence that the loss of
plasmids correlates with the loss of infectivity of the Lyme disease
spirochetes. In this study we have further investigated this
correlation. Clonal populations were obtained from the skin of a mouse
infected for 3 months with a clonal population of Borrelia burgdorferi B31MI. The complete plasmid compositions of these populations were determined using a combination of PCR and Southern hybridization. The infectivities of clones differing in plasmid composition were tested using the C3H-HeJ murine model for Lyme disease. While several clones were found to be noninfectious, a
correlation between the loss of a specific plasmid and loss of
infectivity in the clones analyzed in this report was not observed. While it is clear from recent studies that the loss of some specific plasmids results in attenuated virulence, this study demonstrates that
additional mechanisms also contribute to the loss of infectivity.
 |
INTRODUCTION |
Infection with pathogenic species of
the Borrelia burgdorferi sensu lato complex can lead to Lyme
disease, an infection characterized by highly variable multisystem
clinical manifestations (30, 31). Early studies suggested
that plasmid-encoded proteins play an important role in
Borrelia pathogenesis (26, 28), and in recent
years it has been demonstrated that they also play an important role in
immune evasion (37, 43). In addition, several
plasmid-borne genes have been demonstrated to be up-regulated during
infection, supporting a functional role for the proteins in the
mammalian environment (1, 11, 39). The ability to define a
correlation between specific plasmids and infectivity has until
recently been complicated by the inherent instability of the
Borrelia plasmids and the variation in plasmid content among
isolates (3, 9, 17, 18, 20, 25, 28, 29, 40, 41). Prior to
the determination of the complete genome sequence and plasmid content of B. burgdorferi, these features made it difficult to
interpret and compare much of the earlier data. Determination of the
genome sequence of B. burgdorferi B31MI and other analyses
revealed the existence of both linear and circular comigrating plasmids
of between 24 and 56 kb that could not be distinguished by agarose gel
electrophoresis (5, 10, 15, 35). There are also several distinct yet closely related circular plasmids (designated cp) of
approximately 32 kb (cp32) (33, 35) and multiple linear plasmids (designated lp) of approximately 28 kb (lp28s). The cp32s have
extended regions of homology, while the lp28s have significantly less
identity. In addition to comigrating plasmids, the genome also contains
an extraordinary number of plasmid-carried paralogous gene families
(n = 175). This genetic redundancy, which could allow
for functional complementation of plasmid-encoded proteins, coupled
with the inherent instability of the Borrelia plasmids has
made it difficult to pinpoint one or more specific plasmids as
essential for infectivity (4, 9, 17, 28, 37, 38, 43).
However, two recent independent studies by Labandeira-Rey and Skare and
by Purser and Norris have provided evidence that lp25 and lp28-1 may be
necessary for full virulence (16, 22). These studies
clearly demonstrate that the loss of specific plasmids is one mechanism
by which decreased virulence can occur. It should also be noted that in
a recent study by Siebers et al. (27) it was demonstrated
that clonal variations in pathogenicity arise after infection and
subsequent subsurface plating of the Lyme disease spirochetes. However,
Siebers et al. utilized B. burgdorferi ZS7, an isolate of
undefined genomic composition, and did not determine the plasmid
contents of the clones with different pathogenicities. Hence, the basis
for the loss of infectivity in the clones analyzed was not determined.
In this report, we have continued to assess putative correlations
between plasmid content and infectivity and have employed clonal
populations of defined genetic composition to achieve this goal. By
defining the plasmid compositions of a series of clones derived from an
infectious clone of B. burgdorferi B31MI and then testing
the infectivities of these clones in C3H-HeJ mice, we demonstrate that
loss of infectivity can occur in isolates that still retain lp25 and
lp28-1. While lp25 and lp28-1 appear to be important for infectivity,
the data presented here demonstrate that mechanisms in addition to the
loss of these plasmids can also lead to the loss of infectivity.
 |
MATERIALS AND METHODS |
Generation of postinfection isogeneic clones of B. burgdorferi B31MI.
All analyses were conducted using the
cloned isolate B. burgdorferi B31MI (kindly provided by Mark
Hanson at MedImmune Inc., Gaithersburg, Md.), designated the parental
clone (pc), and clonal populations derived from it. This isolate was
selected for analysis because the sequence of its entire genome is now
available (http://www.tigr.org) (15). Upon receipt of the
isolate, its infectivity was confirmed using the C3H-HeJ murine model
for Lyme disease as previously described (37). In brief,
103 spirochetes were needle inoculated intradermally
between the shoulder blades of three 6-week-old C3H-HeJ mice. After 4 weeks, 1-mm-diameter ear punch biopsy specimens were collected and
placed in BSK-H complete medium (Sigma) containing antibiotics
(phosphomycin, 20 µg ml
1; rifampin, 50 µg
ml
1; amphotericin, 2.5 µg ml
1; Sigma).
After the infection was confirmed, it was allowed to persist for a
total of 3 months. At this point, ear punch biopsy specimens were again
collected and placed in medium for cultivation as described above. The
spirochetes were maintained in this medium until growth became evident
as determined by dark-field microscopy and were then subsurface plated
(37). Colonies were evident after approximately 2 weeks,
and well-isolated colonies were selected for analysis. These
populations are henceforth referred to as postinfection clonal populations.
PCR analyses.
PCR analyses were performed using isolated DNA
or DNA released from lysed cells as a template. When lysed cells were
used as a template, 1 ml of culture (~2.0 × 108
cells) was pelleted (14,500 × g; 5 min), and the cells
were resuspended in phosphate-buffered saline (pH 7.4) and enumerated
by dark-field microscopy. The cells were pelleted, resuspended in
sterile water (5 × 106 cells/µl), and boiled for 5 min;
the cellular debris was removed by centrifugation, and the supernatant
was transferred to a new tube for use as the template in PCR analyses.
PCR was performed using DNA from 5 × 106 cells, 300 to 400 pg of each primer pair (Table 1),
Supermix (Gibco-BRL), and 0.4 U of recombinant Taq in a
reaction volume of 20 µl. The reaction mixtures were overlaid with
mineral oil, and PCR was performed as follows: 1 min at 94°C followed
by 35 cycles of 1 min at 94°C, 1 min at 45°C, and 2 min at 72°C.
A final extension step of 72°C for 6 min was performed. The amplicons
were analyzed in 1% agarose gels containing 0.5 µg of ethidium
bromide/ml. Positive controls included a low-passage, infectious,
wild-type clonal isolate derived from B31 (MSK5) known to contain most
of the known B. burgdorferi plasmids (16) and
B. burgdorferi B31MIpc, for which the entire plasmid content
and genome sequence are known. The absence of specific plasmids,
inferred from a negative PCR result, was confirmed through Southern
hybridization analyses as described below.
Southern hybridization analyses.
Isolated genomic DNA from
each clonal population, obtained as previously described
(18), was digested with HaeIII (standard conditions) and fractionated by electrophoresis in 0.8% agarose gels.
The DNA was stained with ethidium bromide and transferred onto Hybond N
membranes by vacuum blotting, using the VacuGene system (Pharmacia) and
protocols provided by the manufacturer. The DNA was fixed to the
membrane by UV irradiation using the Bio-Rad GS Gene Linker.
Hybridization conditions, washes, and oligonucleotide probe labeling
were as previously described (6). All oligonucleotide
probes and primers are described in Table 1.
Analysis of the infectivity of B. burgdorferi clones
in mice.
The infectivities of B. burgdorferi B31MI
clones were tested using the murine model for Lyme disease infection.
The infective potential of B. burgdorferi B31MIpc has been
previously established, and we have experienced a 100% success rate in
the recovery of spirochetes from experimentally infected C3H-HeJ mice
(n = 30) by cultivation of ear punch biopsy specimens
(37). In the first round of experiments designed to test
for infectivity, an inoculum of ~500 spirochetes was used. In the
second round of experiments, three mice were inoculated with
107 spirochetes each. Ear punch biopsy specimens were
collected at 4 and 12 weeks postinoculation and placed in BSK-H
complete medium containing antibiotics. After 12 weeks, the mice were
sacrificed and the spleens, kidneys, and blood were collected and
placed individually in BSK-H complete medium.
 |
RESULTS |
Analysis of the cp32 plasmid family in pre- and postinfection
clonal populations derived from B. burgdorferi
B31MIpc.
We began our assessment of a possible correlation between
specific plasmids and infectivity by determining the cp32 plasmid compositions of several clonal populations derived from B. burgdorferi B31MIpc. We initially focused on the cp32a, since
these plasmids carry several gene families suggested to contribute to
pathogenicity (21, 32, 36, 37, 42). C3H-HeJ mice were
infected for 3 months, and then postinfection clonal populations were
collected (n = 100). The composition of the cp32
plasmid family was determined for several clones by using a
hybridization approach. The preinfection clonal population was
confirmed to harbor seven cp32s (Table
2). All oligonucleotide probes used in
this report were designed based on the B. burgdorferi B31MI
genome sequence (9). The uhb(+) oligonucleotide targets a
segment of the cp32s that is referred to as the upstream homology box
(UHB) element (19). This conserved element resides
upstream of three different lipoprotein-encoding gene families
(ospE, ospF, and family 163) that are carried by the cp32s
(and lp56) (2, 4, 15, 19, 35, 38). Note that the
designation "family 163" was devised by The Institute for Genomic
Research (15). Using the known cp32 sequences for B. burgdorferi B31MI, the sizes of HaeIII restriction
fragments derived from each plasmid that carry target sites for each
probe could be deduced (Table 3), thereby
allowing the determination of which cp32s were present or absent. All
clones were found to carry several uhb(+)-hybridizing fragments, with 7 of 20 clones exhibiting hybridization profiles identical to that of
B. burgdorferi B31MIpc (Fig. 1
shows representative data). cp32-4 and cp32-3 were present in all
clones, while others lacked cp32-6, cp32-9, and/or cp32-7. The loss of
these plasmids was confirmed through additional hybridization analyses
using oligonucleotides targeting other regions of the plasmids. For
example, the loss of cp32-6 was confirmed using a probe targeting the
BBM38 gene (Fig. 2). In all other cases,
these additional analyses corroborated the absence of these plasmids
from certain clones. In some additional cases, plasmid-specific probes
were required to ascertain the presence or absence of specific
plasmids. For example, both cp32-8 and cp32-1 are predicted to yield
HaeIII restriction fragments of 2,048 bp that possess
binding sites for the uhb(+) probe; hence, to differentiate between
these plasmids, additional probes were required. A plasmid-specific
probe was required for cp32-4 as well. The BBL, BBP, and ospF-R
oligonucleotides are specific for plasmids cp32-8, cp32-1, and cp32-4,
respectively. Hybridization analyses revealed that these plasmids were
carried by all clones. The results of the hybridization analyses are
summarized in Table 2.
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Summary of plasmid profiles and infective potentials of
postinfection clonal populations of B. burgdorferi
B31MIa
|
|

View larger version (53K):
[in this window]
[in a new window]
|
FIG. 1.
Restriction fragment length polymorphism pattern
analysis of the cp32 family of plasmids. DNA was isolated from each
clone, digested with HaeIII, fractionated by agarose gel
electrophoresis, transferred onto Hybond N membrane by vacuum blotting,
and hybridized with the 32P-labeled uhb(+) oligonucleotide
as described in the text. The clones analyzed are indicated above each
lane, and the plasmid from which each hybridizing restriction fragment
was derived is indicated on the right. The migration positions for the
size standards are indicated between the panels. pc indicates DNA from
the parental clone, B31MI.
|
|

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 2.
Confirmation through Southern hybridization analyses of
the loss of cp32-6 from clones. HaeIII-digested DNA from
each clone (indicated above each lane) was fractionated and blotted as
described in the legend to Fig. 1 and then hybridized with the BBM38-
targeting cp32-6 probe. pc indicates DNA from the parental clone,
B31MI.
|
|
The linear plasmid lp56 carries an integrated cp32 (9) and
is predicted to yield a uhb(+)-hybridizing HaeIII
restriction fragment of 869 bp. An appropriately sized hybridizing
restriction fragment was detected in all clones analyzed (data not
shown). This hybridization band is not visible in Fig. 1, as it was
necessary to run it off the gel in order to obtain maximal separation
of other similarly sized UHB-carrying restriction fragments.
Analysis of infectivities of clonal populations derived from
B. burgdorferi B31MIpc that differ in their cp32 plasmid
compositions.
To determine if the observed variation in cp32
composition influences the abilities of clonal populations to establish
infection in mice, clones lacking one or more cp32s were needle
inoculated into C3H-HeJ mice. Initial experiments were performed using
an inoculum of 103 spirochetes for the parental clone and
clones 17, 24, and 53. At 1 and 3 months postinoculation, ear punch
biopsy specimens and blood were recovered and placed in complete BSK-H
medium to allow cultivation of the spirochetes. Positive cultures were
obtained for clones 53 and pc from both the 1- and 3-month time points, while all other cultures were negative. To allow for the possibility that the kinetics of growth might be slower for some clones, the cultures were allowed to persist for 2 months. However, even after this
time only clones 53 and pc were culture positive. The experiment was
repeated using three mice per clone, an inoculum of 107
spirochetes, and a broader range of clones (clones pc, 9, 14, 24, 29, 36, 37, and 53). At 1 month postinoculation, positive cultures were
obtained for clones pc, 29, 36, 37, and 53 but not clones 9, 14, 17, and 24. At 3 months postinoculation, the mice were sacrificed, and ear
punch biopsy specimens, blood, spleens, and kidneys were collected.
Clones pc 29, 36, 37, and 53 were culture positive, whereas clones 9, 14, 17, and 24 were culture negative for all tissues tested.
Complete analysis of the plasmid compositions of
infectious and noninfectious clonal populations derived from B. burgdorferi B31 MI.
To determine if there were additional
differences in the linear- and non-cp32 circular-plasmid profiles in
the infectious and noninfectious clonal isolates described above, a PCR
strategy was employed to test for each plasmid. B. burgdorferi B31MIpc and B. burgdorferi MSK5 served as
positive controls to verify that the primers were specific.
Amplification was scored as follows:
, no amplification; +/
, weak
amplification; and +, strong amplification. Weak amplification may
indicate that certain plasmids have been lost from the majority of the
population. Upon PCR, all primer sets yielded amplicons of the expected
sizes. Representative PCR results are shown in Fig.
3, and the data are summarized in Table 2. Several clones were found to lack one or more different plasmids. The plasmids found to be lost from one or more clones included lp5,
lp28-2, lp28-3, cp9, cp32-6, or cp32-9. In addition, as previously reported, we did not detect plasmids cp32-2 and cp32-5 in B. burgdorferi B31 MIpc or (not surprisingly) in any of its clonal
derivatives. Several clones were found to have lost as many as four
different plasmids relative to the parental population.

View larger version (62K):
[in this window]
[in a new window]
|
FIG. 3.
Determination of the plasmid compositions of B. burgdorferi B31MI clones by using a PCR approach. Isolated genomic
DNA served as a template for PCR analyses using plasmid-specific primer
sets. Amplification products were fractionated on a 1% agarose gel and
stained with ethidium bromide. The gel was then scanned to generate the
figure. All methods were as described in the text. On the left, the
B. burgdorferi B31MI clones analyzed and the migration
positions of the size standards are indicated. The plasmid tested for
is indicated above each lane.
|
|
To confirm the negative PCR results obtained for some
plasmids, Southern hybridization analyses were performed (the
hybridization analyses of the cp32s are described separately). For
example, using an oligonucleotide specific for lp28-3 (BBH08) as a
probe, we confirmed that the plasmid had
been lost from all postinfection clonal populations (Fig. 4).

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 4.
Southern hybridization analysis of lp28-3.
HaeIII-digested DNA from each clone (indicated above each
lane) was fractionated and blotted as described in the legend to Fig.
1. The blot was hybridized with the lp28-3 targeting probe, BBH08.
Molecular standards are indicated on the left. pc, indicates DNA from
the parental clone, B31MI.
|
|
 |
DISCUSSION |
Several studies have demonstrated that loss of infectivity is
associated with plasmid loss in the Lyme disease spirochetes (26,
41) and that this is the primary mechanism associated with the
phenomenon. One of the first studies to suggest that such a correlation
exists was conducted by Schwan and colleagues (26), where
the loss of cp7.6 and lp22 was concomitant with the loss of
infectivity. It is unclear if B. burgdorferi B31MI carries
homologs of these plasmids, since the sequences for these plasmids were
not determined. It is likely that cp7.6 is analogous to cp9.0
(13, 15). Analysis of cp9.0 revealed that it does not
appear to encode proteins with homology to proteins known to
participate in virulence. In this report, we demonstrate that several
clones that have lost this plasmid remain infective. A similar
observation has recently been reported by Purser and Norris and by
Labandeira-Rey and Skare (16, 22). However, the absence of
a strict requirement for cp9.0 should not be interpreted to suggest
that cp9.0-encoded proteins are not potentially important in
Borrelia pathogenesis. Most of the open reading frames
present on cp9.0 are actually members of plasmid-carried paralogous
gene families (5, 15), so paralogs encoded by other
plasmids might complement lost functions. The identification of a
homolog of lp22, a second plasmid linked to virulence by Schwan et al.
(26), in B. burgdorferi B31MI is complicated by
the presence of numerous linear plasmids in this isolate, ranging from
17 to 30 kb. Other linear plasmids in this size range have also been
implicated as necessary for virulence. The loss of lp28.7 coincides
with an increase in the 50% infective dose (ID50),
(40, 41). This plasmid is likely a homolog of one of the
four lp28s present in the B. burgdorferi B31MI genome
(8). In general, the complete plasmid contents of the
isolates analyzed in these earlier studies were largely unknown, making
it difficult to interpret the data and to compare it with the data
obtained from other studies that used different isolates. Hence, while
a correlation between plasmids and infectivity appeared to exist, the
specific plasmids associated with the phenomenon remained elusive.
In this study, we have focused our analyses on clonal populations
derived from B. burgdorferi B31MI. The genome sequence for this isolate has recently been determined, allowing these studies to be
conducted with an isolate of known genetic composition
(15). Other recent studies of this topic have also
exploited the genome sequence in their analyses of plasmid composition
and infectivity (16, 22). The studies described here began
with a particular interest in the possible role of the cp32 plasmid
family in infectivity and virulence. Analyses conducted by our
laboratory and others have demonstrated that several of the genes
carried by these plasmids are differentially expressed during infection
(1, 12, 36, 39; J. V. McDowell, S.-Y. Sung, G. Price,
and R. T. Marconi, submitted for publication) and that some may
play a role in immune evasion (37). An initial assessment
of cp32 compositions in different B31MI-derived clones led to the
identification of several with differing cp32 restriction fragment
length polymorphism patterns. To determine if these variants were
infective, we employed the C3H-HeJ mouse model. Initial analyses
utilized low inoculating doses of ~500 spirochetes (intradermal
inoculation), and infectivity was assessed by the ability to cultivate
the bacteria from ear punch biopsy specimens. We found that several of
the clones were not infective. One possibility was that these
particular clones might simply have altered ID50s. To
maximize the potential establishment of infection, we used a high
inoculating dose of ~107 spirochetes. As before, the same
results were obtained for each clone. In addition, cultures of other
tissues and organs from the mice that were culture negative with the
ear punch biopsy specimens were also culture negative. Hence, the
phenomenon that we observed was that the clones were either infectious
or noninfectious. The use of two different inoculum sizes (500 and
107 spirochetes) that are at opposite ends of the scale but
yielded the same results demonstrates that the molecular events that
occurred in these clones did not simply alter the ID50. It
is important to note that the 107-spirochete inoculating
dose had no discernible negative impact on any of the inoculated mice.
In assessing these data, a clear-cut correlation between the loss of
any one specific cp32 and the loss of infectivity was not discernible.
Recent studies conducted by others have reached similar conclusions
(16, 22). From this, we conclude that a complete set of
all seven cp32s is not required for infectivity, maintenance of
infection, or in vitro cultivation. The apparent lack of a requirement
for a complete set of cp32s is consistent with the extensive variation
in composition that has been demonstrated for this plasmid family in a
wide range of isolates (19, 38). However, in view of the
extensive genetic redundancy among the cp32s, it is perhaps not
surprising that the loss of a subset of these genetic elements would
have miminal impact on infectivity, virulence, or the ability to grow
in vitro, since the proteins encoded by the multiple cp32s may
complement each other. It should be noted that lp56 also contains an
integrated cp32 and could serve to complement functions lost through
the loss of cp32s (8). Interestingly, all Lyme disease
isolates analyzed, as well as relapsing fever isolates, carry at least some cp32s (6, 7, 19, 23, 24, 34, 38). This observation suggests that maintenance of at least a subset of these plasmids is a
necessary biological feature at the genus-wide level. It is important
to note that the clones analyzed in this report were only briefly
cultivated postinfection, suggesting that the changes in cp32 plasmids
occurred during infection. Alternatively, the plasmids could have been
lost during the postinfection cultivation period. Several observations
argue against this. We have found that the cp32s of Borrelia
garinii Pbi were retained after 311 in vitro passages (~4 years
of continuous cultivation) (R. T. Marconi, unpublished data).
Furthermore, to our knowledge, the loss of cp32s specifically during in
vitro cultivation has not been reported. Hence, the cp32s may actually
be less stable during infection than they are during in vitro
cultivation. Studies by Eggers and Samuels suggest that the cp32s may
actually encode prophage (14). It is possible that the
mammalian environment stimulates bacteriophage transduction or plasmid
transfer during infection, leading to changes in cp32 composition.
To determine if there might be a correlation between the loss of other
plasmids and infectivity, we determined the complete plasmid
compositions of several clones that were found in the analyses above to
be either infectious or noninfectious. lp28-3 was the only plasmid
absent from all noninfectious clones. lp28 is one of four similarly
sized linear plasmids carried by B. burgdorferi B31MI
(15). The specific absence of this plasmid was confirmed by both PCR and Southern hybridization. While we initially interpreted these data to suggest a correlation between Ip28-3 and infectivity, additional analyses of other infectious clones revealed that some of
them also lacked lp28-3. Analysis of clones lacking this plasmid revealed that they were infective even when an inoculum of ~500 spirochetes was used. Hence, it is evident that lp28-3 is not strictly
required for infectivity and that its loss does not affect the
ID50. Two of the lp28-3-minus infectious clones also lacked lp28-2. In a previous analysis, it was demonstrated that the loss of an
~28-kb linear plasmid correlated with an increase in ID50 from 103 to 105 in the hamster model
(41). However, in that study it was not specifically
determined which of the four lp28s was lost. In an analysis of linear
plasmids, Palmer et al. demonstrated that lp28-1, lp28-3, lp28-4, lp36,
and lp54 were carried by all 15 Lyme disease spirochete isolates
analyzed. They interpreted this to mean that these plasmids are
biologically necessary (20). However, the data presented
here demonstrate that the loss of lp28-3 and lp28-2 does not abrogate
the ability of B31MI clones to establish and maintain infection. Purser
and Norris also reported that lp28-2 (and lp28-4) is not required for
infectivity (22). In that analysis, the authors did not
test clones lacking lp28-3, since all of the clones in their collection
carried the plasmid. It is possible that the decrease in
ID50 reported by Xu et al. resulted from the loss of lp28-1 (41).
Evidence has recently been presented which demonstrates that the loss
of lp25 and lp28-1 is coincident with a low-infectivity phenotype
(16, 22). However, none of the noninfectious clones analyzed as part of our study had lost either of these plasmids. We do
not believe this to represent a discrepancy between these reports and
the data presented here. Specific plasmids may very well play critical
roles in infectivity or virulence, and the data presented by others
suggest that lp25 and lp28-1 are in this category. What is striking is
that in the three recent reports that have assessed the possible link
between specific plasmids and infectivity, the specific plasmids lost
by the clonal populations differed widely. We found that most of the
clones analyzed in this report had lost lp28-3, while this plasmid was
universally present in the clones analyzed by Purser and Norris and
Labandeira-Rey and Skare. A second notable difference was in the cp32s.
Purser and Norris found that all of the cp32s, with the exception of cp32-3, which was lost from only a single clone (B. burgdorferi 5A3), were retained (note that Labandeira and Skare
did not determine the complete composition of the cp32 plasmid family
in all clones analyzed). In contrast, we found that six of the eight
clones derived from B. burgdorferi B31MI pc had lost one or
more cp32s. The data presented here suggest that undefined mechanisms
independent of the loss of a specific plasmid can also lead to the loss
of infectivity. In addition, it is also evident from the variation noted in this and other recent studies that the dynamics of plasmid loss can vary widely under different experimental conditions (16, 22).
The central point of the analyses presented here is that the loss of
infectivity does not in all cases correlate with the loss of a specific
plasmid. However, this is not to say that such a correlation does not
exist. It remains possible that there is an essential plasmid or
combination of plasmids that are required for infectivity and
virulence. In view of the genetic redundancy among the plasmids and
thus the potential for complementation of function, it would seem most
likely that this putative essential plasmid would be one of those that
carries genes not harbored by other elements of the genome so that
complementation could not occur. Perhaps a possible biological role for
the redundancy in the Lyme disease spirochete genome is to shield the
bacteria from the potentially adverse consequences associated with the inherent instability of its plasmid-based genome. Studies by others suggest that lp25 and lp28-1 are possible essential plasmids (16, 22). Nonetheless, even though certain plasmids may prove
essential, the data presented here demonstrate that other mechanisms
independent of plasmid loss appear to also be at play. These may
include small-scale mutations or rearrangements in essential genes
and/or differences in gene expression patterns among clonal
populations. The analyses presented here provide further insight into
the fluid nature of the Borrelia genome and the mechanisms
associated with loss of infectivity. Furthermore, this study
illustrates the complexity of assessing the contribution of the plasmid
component of the Borrelia genome to the biology and
pathogenesis of the Lyme disease spirochetes.
We thank our colleagues in the Molecular Pathogenesis group at
VCU for their helpful discussions. We especially thank our laboratory
coworkers D. M. Roberts, M. S. Metts, and F. Sutton for their
help and advice. R. T. Marconi wishes to acknowledge Devin Marconi
for thoughtful late-night discussions.
This work was supported in part by a grant from the Jeffress Trust and
an R29 award from the NIAID, NIH. J. V. McDowell was also
supported in part by a training grant provided to the Department of
Microbiology and Immunology, MCV at VCU, by NIAID, NIH. J. T. Skare and M. Labandeira-Rey were supported in part by grants from the
NIAID, NIH (R01-AI42345), and the American Heart Association.
| 1.
|
Akins, D.,
S. F. Porcella,
T. G. Popova,
D. Shevchenko,
S. I. Baker,
M. Li,
M. V. Norgard, and J. D. Radolf.
1995.
Evidence for in vivo but not in vitro expression of a Borrelia burgdorferi outer surface protein F (OspF) homologue.
Mol. Microbiol.
18:507-520[CrossRef][Medline].
|
| 2.
|
Akins, D. R.,
M. J. Caimano,
X. Yang,
F. Cerna,
M. V. Norgard, and J. D. Radolf.
1999.
Molecular and evolutionary analysis of Borrelia burgdorferi 297 circular plasmid-encoded lipoproteins with OspE- and OspF-like leader peptides.
Infect. Immun.
67:1526-1532[Abstract/Free Full Text].
|
| 3.
|
Barbour, A. G.
1988.
Plasmid analysis of Borrelia burgdorferi, the Lyme disease agent.
J. Clin. Microbiol.
26:475-478[Abstract/Free Full Text].
|
| 4.
|
Caimano, M. J.,
X. Yang,
T. G. Popova,
M. L. Clawson,
D. R. Akins,
M. V. Norgard, and J. D. Radolf.
2000.
Molecular and evolutionary characterization of the cp32/18 family of supercoiled plasmids in Borrelia burgdorferi 297.
Infect. Immun.
68:1574-1586[Abstract/Free Full Text].
|
| 5.
|
Carlyon, J. A.,
C. LaVoie,
S. Y. Sung, and R. T. Marconi.
1998.
Analysis of the organization of multicopy linear- and circular-plasmid-carried open reading frames in Borrelia burgdorferi sensu lato isolates.
Infect. Immun.
66:1149-1158[Abstract/Free Full Text].
|
| 6.
|
Carlyon, J. A.,
D. M. Roberts, and R. T. Marconi.
2000.
Evolutionary and molecular analyses of the Borrelia bdr super gene family: delineation of distinct sub-families and demonstration of the genus wide conservation of putative functional domains, structural properties and repeat motifs.
Microb. Pathog.
28:89-105[CrossRef][Medline].
|
| 7.
|
Carlyon, J. A.,
D. M. Roberts,
M. Theisen,
C. Sadler, and R. T. Marconi.
2000.
Molecular and immunological analyses of the Borrelia turicatae Bdr protein family.
Infect. Immun.
68:2369-2373[Abstract/Free Full Text].
|
| 8.
|
Casjens, S.
1999.
Evolution of the linear DNA replicons of the Borrelia spirochetes.
Curr. Opin. Microbiol.
2:529-534[CrossRef][Medline].
|
| 9.
|
Casjens, S.,
N. Palmer,
R. van Vugt,
W. M. Huang,
B. Stevenson,
P. Rosa,
R. Lathigra,
G. Sutton,
J. Peterson,
R. J. Dodson,
D. Haft,
E. Hickey,
M. Gwinn,
O. White, and C. M. Fraser.
2000.
A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi.
Mol. Microbiol.
35:490-516[CrossRef][Medline].
|
| 10.
|
Casjens, S.,
R. van Vugt,
K. Tilly,
P. A. Rosa, and B. Stevenson.
1997.
Homology throughout the multiple 32-kilobase circular plasmids in Lyme disease spirochetes.
J. Bacteriol.
179:217-227[Abstract/Free Full Text].
|
| 11.
|
Champion, C. I.,
D. R. Blanco,
J. T. Skare,
D. A. Haake,
M. Giladi,
D. Foley,
J. N. Miller, and M. A. Lovett.
1994.
A 9.0-kilobase-pair circular plasmid of Borrelia burgdorferi encodes an exported protein: evidence for expression only during infection.
Infect. Immun.
62:2653-2661[Abstract/Free Full Text].
|
| 12.
|
Das, S.,
S. W. Barthold,
S. S. Giles,
R. R. Montgomery,
S. R. Telford III, and E. Fikrig.
1997.
Temporal pattern of Borrelia burgdorferi p21 expression in ticks and the mammalian host.
J. Clin. Investig.
99:987-995[Medline].
|
| 13.
|
Dunn, J. J.,
S. R. Buchstein,
L.-L. Butler,
S. Fisenne,
D. S. Polin,
B. N. Lade, and B. J. Luft.
1994.
Complete nucleotide sequence of a circular plasmid from the Lyme disease spirochete, Borrelia burgdorferi.
J. Bacteriol.
176:2706-2717[Abstract/Free Full Text].
|
| 14.
|
Eggers, C., and D. S. Samuels.
1999.
Molecular evidence for a new bacteriophage of Borrelia burgdorferi.
J. Bacteriol.
181:7308-7313[Abstract/Free Full Text].
|
| 15.
|
Fraser, C.,
S. Casjens,
W. M. Huang,
G. G. Sutton,
R. Clayton,
R. Lathigra,
O. White,
K. A. Ketchum,
R. Dodson,
E. K. Hickey,
M. Gwinn,
B. Dougherty,
J. F. Tomb,
R. D. Fleischman,
D. Richardson,
J. Peterson,
A. R. Kerlavage,
J. Quackenbush,
S. Salzberg,
M. Hanson,
R. Vugt,
N. Palmer,
M. D. Adams,
J. Gocayne,
J. Weidman,
T. Utterback,
L. Watthey,
L. McDonald,
P. Artiach,
C. Bowman,
S. Garland,
C. Fujii,
M. D. Cotton,
K. Horst,
K. Roberts,
B. Hatch,
H. O. Smith, and J. C. Venter.
1997.
Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi.
Nature
390:580-586[CrossRef][Medline].
|
| 16.
|
Labandeira-Rey, M., and J. T. Skare.
2001.
Decreased infectivity in Borrelia burgdorferi strain B31 is associated with loss of either linear plasmid 25 or 28-1.
Infect. Immun.
69:446-455[Abstract/Free Full Text].
|
| 17.
|
Marconi, R. T.,
S. Casjens,
U. G. Munderloh, and D. S. Samuels.
1996.
Analysis of linear plasmid dimers in Borrelia burgdorferi sensu lato isolates: implications concerning the potential mechanism of linear plasmid replication.
J. Bacteriol.
178:3357-3361[Abstract/Free Full Text].
|
| 18.
|
Marconi, R. T.,
D. S. Samuels,
R. K. Landry, and C. F. Garon.
1994.
Analysis of the distribution and molecular heterogeneity of the ospD gene among the Lyme disease spirochetes: evidence for lateral gene exchange.
J. Bacteriol.
176:4572-4582[Abstract/Free Full Text].
|
| 19.
|
Marconi, R. T.,
S. Y. Sung,
C. N. Hughes, and J. A. Carlyon.
1996.
Molecular and evolutionary analyses of a variable series of genes in Borrelia burgdorferi that are related to ospE and ospF, constitute a gene family, and share a common upstream homology box.
J. Bacteriol.
178:5615-5626[Abstract/Free Full Text].
|
| 20.
|
Palmer, N.,
C. Fraser, and S. Casjens.
2000.
Distribution of twelve linear extrachromosomal DNAs in natural isolates of Lyme disease spirochetes.
J. Bacteriol.
182:2476-2480[Abstract/Free Full Text].
|
| 21.
|
Porcella, S. F.,
C. A. Fitzpatrick, and J. L. Bono.
2000.
Expression and immunological analysis of the plasmid-borne mlp genes of Borrelia burgdorferi strain B31.
Infect. Immun.
68:4992-5001[Abstract/Free Full Text].
|
| 22.
|
Purser, J. E., and S. J. Norris.
2000.
Correlation between plasmid content and infectivity in Borrelia burgdorferi.
Proc. Natl. Acad. Sci. USA
97:13865-13870[Abstract/Free Full Text].
|
| 23.
|
Roberts, D. M.,
J. A. Carlyon,
M. Theisen, and R. T. Marconi.
2000.
The bdr gene families of the Lyme disease and relapsing fever spirochetes: possible influence on biology, pathogenesis and evolution.
Emerg. Infect. Dis.
6:110-122[Medline].
|
| 24.
|
Roberts, D. M.,
M. Theisen, and R. T. Marconi.
2000.
Analysis of the cellular localization of Bdr paralogs in Borrelia burgdorferi, a causative agent of Lyme disease: evidence for functional diversity.
J. Bacteriol.
182:4222-4226[Abstract/Free Full Text].
|
| 25.
|
Samuels, D. S.,
R. T. Marconi, and C. F. Garon.
1993.
Variation in the size of the ospA-containing linear plasmid, but not the linear chromosome, among the three Borreliaspecies associated with Lyme disease.
J. Gen. Microbiol.
139:2445-2449[Medline].
|
| 26.
|
Schwan, T. G.,
W. Burgdorfer, and C. F. Garon.
1988.
Changes in infectivity and plasmid profile of the Lyme disease spirochete, Borrelia burgdorferi, as a result of in vitro cultivation.
Infect. Immun.
56:1831-1836[Abstract/Free Full Text].
|
| 27.
|
Siebers, A.,
W. Zhong,
R. Wallich, and M. M. Simon.
1999.
Loss of pathogenic potential after cloning of the low-passage Borrelia burgdorferi ZS7 tick isolate: a cautionary note.
Med. Microbiol. Immunol.
188:125-130[CrossRef][Medline].
|
| 28.
|
Simpson, W. J.,
C. F. Garon, and T. G. Schwan.
1990.
Analysis of supercoiled circular plasmids in infectious and non-infectious Borrelia burgdorferi.
Microb. Pathog.
8:109-118[CrossRef][Medline].
|
| 29.
|
Simpson, W. J.,
C. F. Garon, and T. G. Schwan.
1990.
Borrelia burgdorferi contains repeated DNA sequences that are species specific and plasmid associated.
Infect. Immun.
58:847-853[Abstract/Free Full Text].
|
| 30.
|
Steere, A. C.,
R. L. Grodzicki,
A. N. Kornblatt,
J. E. Craft,
A. G. Barbour,
W. Burgdorfer,
G. P. Schmid,
E. Johnson, and S. E. Malawista.
1983.
The spirochetal etiology of Lyme disease.
N. Engl. J. Med.
308:733-740[Abstract].
|
| 31.
|
Steere, A. C.,
S. E. Malawista,
D. R. Snydman,
R. E. Shope,
W. A. Andiman,
M. R. Ross, and F. M. Steele.
1977.
Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities.
Arthritis Rheum.
20:7-17[Medline].
|
| 32.
|
Stevenson, B.,
J. L. Bono,
T. G. Schwan, and P. Rosa.
1998.
Borrelia burgdorferi Erp proteins are immunogenic in mammals infected by tick bite, and their synthesis is inducible in cultured bacteria.
Infect. Immun.
66:2648-2654[Abstract/Free Full Text].
|
| 33.
|
Stevenson, B.,
S. Casjens,
R. van Vugt,
S. F. Porcella,
K. Tilly,
J. L. Bono, and P. Rosa.
1997.
Characterization of cp18, a naturally truncated member of the cp32 family of Borrelia burgdorferi plasmids.
J. Bacteriol.
179:4285-4291[Abstract/Free Full Text].
|
| 34.
|
Stevenson, B.,
S. F. Porcella,
K. L. Oie,
C. A. Fitzpatrick,
S. J. Raffel,
L. Lubke,
M. E. Schrumpf, and T. G. Schwan.
2000.
The relapsing fever spirochete Borrelia hermsii contains multiple antigen-encoding circular plasmids that are homologous to the cp32 plasmids of Lyme disease spirochetes.
Infect. Immun.
68:3900-3908[Abstract/Free Full Text].
|
| 35.
|
Stevenson, B.,
K. Tilly, and P. A. Rosa.
1996.
A family of genes located on four separate 32-kilobase circular plasmids in Borrelia burgdorferi B31.
J. Bacteriol.
178:3508-3516[Abstract/Free Full Text].
|
| 36.
|
Suk, K.,
S. Das,
W. Sun,
B. Jwang,
S. W. Barthold,
R. A. Flavell, and E. Fikrig.
1995.
Borrelia burgdorferi genes selectively expressed in the infected host.
Proc. Natl. Acad. Sci. USA
92:4269-4273[Abstract/Free Full Text].
|
| 37.
|
Sung, S. Y.,
J. McDowell,
J. A. Carlyon, and R. T. Marconi.
2000.
Mutation and recombination in the upstream homology box-flanked ospE-related genes of the Lyme disease spirochetes result in the development of new antigenic variants during infection.
Infect. Immun.
68:1319-1327[Abstract/Free Full Text].
|
| 38.
|
Sung, S.-Y.,
C. LaVoie,
J. A. Carlyon, and R. T. Marconi.
1998.
Genetic divergence and evolutionary instability in ospE-related members of the upstream homology box gene family in Borrelia burgdorferi sensu lato complex isolates.
Infect. Immun.
66:4656-4668[Abstract/Free Full Text].
|
| 39.
|
Wallich, R.,
C. Brenner,
M. D. Kramer, and M. M. Simon.
1995.
Molecular cloning and immunological characterization of a novel linear-plasmid-encoded gene, pG, of Borrelia burgdorferi expressed only in vivo.
Infect. Immun.
63:3327-3335[Abstract].
|
| 40.
|
Xu, Y., and R. C. Johnson.
1995.
Analysis and comparision of plasmid profiles of Borrelia burgdorferi sensu lato strains.
J. Clin. Microbiol.
33:2679-2685[Abstract].
|
| 41.
|
Xu, Y.,
C. Kodner,
L. Coleman, and R. C. Johnson.
1996.
Correlation of plasmids with infectivity of Borrelia burgdorferi sensu stricto type strain B31.
Infect. Immun.
64:3870-3876[Abstract].
|
| 42.
|
Yang, X.,
T. G. Popova,
K. E. Hagman,
S. K. Wikel,
G. B. Schoeler,
M. J. Caimano,
J. D. Radolf, and M. Norgard.
1999.
Identification, characterization, and expression of three new members of the Borrelia burgdorferi Mlp (2.9) lipoprotein gene family.
Infect. Immun.
67:6008-6018[Abstract/Free Full Text].
|
| 43.
|
Zhang, J.-R.,
J. M. Hardham,
A. G. Barbour, and A. G. Norris.
1997.
Antigenic variation in Lyme disease Borreliae by promiscuous recombination of vmp like sequence cassettes.
Cell
89:275-285[CrossRef][Medline].
|